Chee Wai Chua

3.0k total citations
29 papers, 1.6k citations indexed

About

Chee Wai Chua is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Chee Wai Chua has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Chee Wai Chua's work include Prostate Cancer Treatment and Research (16 papers), Cancer, Lipids, and Metabolism (4 papers) and Cancer Cells and Metastasis (4 papers). Chee Wai Chua is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Cancer, Lipids, and Metabolism (4 papers) and Cancer Cells and Metastasis (4 papers). Chee Wai Chua collaborates with scholars based in Hong Kong, China and United States. Chee Wai Chua's co-authors include Ming‐Tat Ling, Chun Zhou, Xianghong Wang, Tracy C.M. Lau, Wai Kei Kwok, Xianghong Wang, Franky Leung Chan, Yong-Chuan Wong, Xiaomeng Zhang and Carlotta A. Glackin and has published in prestigious journals such as Nature Communications, Nature Cell Biology and Cancer Research.

In The Last Decade

Chee Wai Chua

29 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chee Wai Chua Hong Kong	18	1.0k	741	484	406	125	29	1.6k
Daniel Wetterskog United Kingdom	20	868 0.8×	604 0.8×	378 0.8×	527 1.3×	159 1.3×	42	1.6k
Pedro P. López‐Casas Spain	25	702 0.7×	978 1.3×	340 0.7×	540 1.3×	125 1.0×	52	1.8k
Yoshimi Arima Japan	27	1.2k 1.1×	906 1.2×	291 0.6×	396 1.0×	93 0.7×	46	2.0k
Ian A.J. Lorimer Canada	21	710 0.7×	518 0.7×	308 0.6×	399 1.0×	129 1.0×	41	1.3k
Pinaki Bose Canada	20	1.0k 1.0×	728 1.0×	227 0.5×	357 0.9×	114 0.9×	42	1.8k
Birunthi Niranjan Australia	16	838 0.8×	435 0.6×	326 0.7×	200 0.5×	103 0.8×	30	1.4k
Katrin E. Tagscherer Germany	22	897 0.9×	564 0.8×	227 0.5×	368 0.9×	110 0.9×	46	1.5k
Roxanne Toivanen Australia	15	597 0.6×	558 0.8×	937 1.9×	374 0.9×	121 1.0×	21	1.5k
Matthew T. Harbison United States	8	853 0.8×	924 1.2×	275 0.6×	362 0.9×	69 0.6×	8	1.6k

Countries citing papers authored by Chee Wai Chua

Since Specialization

Citations

This map shows the geographic impact of Chee Wai Chua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chee Wai Chua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chee Wai Chua more than expected).

Fields of papers citing papers by Chee Wai Chua

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chee Wai Chua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chee Wai Chua. The network helps show where Chee Wai Chua may publish in the future.

Co-authorship network of co-authors of Chee Wai Chua

This figure shows the co-authorship network connecting the top 25 collaborators of Chee Wai Chua. A scholar is included among the top collaborators of Chee Wai Chua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chee Wai Chua. Chee Wai Chua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yong Jian, Bin Yu, Chun‐Wai Mai, et al.. (2022). TP53 loss‐of‐function causes vulnerability to autophagy inhibition in aggressive prostate cancer. International Journal of Urology. 29(9). 1085–1094. 6 indexed citations

Chua, Chee Wai, et al.. (2022). Exploring prostate cancer in the post-genomic era. Cancer Letters. 553. 215992–215992. 3 indexed citations

Mai, Chun‐Wai, Kok‐Yong Chin, Kok-Lun Pang, et al.. (2022). Modeling prostate cancer: What does it take to build an ideal tumor model?. Cancer Letters. 543. 215794–215794. 16 indexed citations

Rong, Lijie, Tomasz B. Owczarek, Rivka L. Shoulson, et al.. (2021). Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression. Cancer Research. 81(20). 5161–5175. 16 indexed citations

Dong, Baijun, Juju Miao, Yanqing Wang, et al.. (2020). Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer. Communications Biology. 3(1). 778–778. 102 indexed citations

Wang, Xue, Haibo Xu, Chaping Cheng, et al.. (2020). Identification of a Zeb1 expressing basal stem cell subpopulation in the prostate. Nature Communications. 11(1). 706–706. 47 indexed citations

Hanoun, Maher, Anna Arnal Estape, Maria Maryanovich, et al.. (2019). Nestin+NG2+ Cells Form a Reserve Stem Cell Population in the Mouse Prostate. Stem Cell Reports. 12(6). 1201–1211. 9 indexed citations

Chua, Chee Wai, Nusrat J Epsi, Eva Leung, et al.. (2018). Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation. eLife. 7. 33 indexed citations

Chua, Chee Wai, Maho Shibata, Ming Lei, et al.. (2014). Single luminal epithelial progenitors can generate prostate organoids in culture. Nature Cell Biology. 16(10). 951–961. 268 indexed citations

10.

Chua, Chee Wai, Yung‐Tuen Chiu, Kwok-Wah Chan, et al.. (2010). Differential expression of MSX2 in nodular hyperplasia, high‐grade prostatic intraepithelial neoplasia and prostate adenocarcinoma. Apmis. 118(12). 918–926. 8 indexed citations

11.

Chua, Chee Wai, Yung‐Tuen Chiu, Hiu‐Fung Yuen, et al.. (2009). Suppression of Androgen-Independent Prostate Cancer Cell Aggressiveness by FTY720: Validating Runx2 as a Potential Antimetastatic Drug Screening Platform. Clinical Cancer Research. 15(13). 4322–4335. 45 indexed citations

12.

Chan, Yuen Piu, Chee Wai Chua, Cian M. McCrudden, et al.. (2009). Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1. British Journal of Cancer. 102(2). 332–341. 19 indexed citations

13.

Yuen, Hiu‐Fung, Chee Wai Chua, Yingying Chu, et al.. (2008). TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction. Carcinogenesis. 29(8). 1509–1518. 47 indexed citations

14.

Leung, Steve C.L., et al.. (2008). Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer. Clinical & Experimental Metastasis. 25(5). 497–508. 40 indexed citations

15.

Chua, Chee Wai, et al.. (2008). Evidence of a novel docetaxel sensitizer, garlic‐derived S‐allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer. International Journal of Cancer. 122(9). 1941–1948. 28 indexed citations

16.

Li, Xia, et al.. (2007). Prognostic significance of Id‐1 and its association with EGFR in renal cell cancer. Histopathology. 50(4). 484–490. 22 indexed citations

17.

Zhang, Zheng, Dan Xie, Xin Li, et al.. (2007). Significance of TWIST expression and its association with E-cadherin in bladder cancer. Human Pathology. 38(4). 598–606. 101 indexed citations

18.

Ding, Yi, Gang Wang, Ming Tat Ling, et al.. (2006). Significance of Id-1 up-regulation and its association with EGFR in bladder cancer cell invasion. International Journal of Oncology. 28(4). 847–54. 36 indexed citations

19.

Kwok, Wai Kei, Ming‐Tat Ling, Tracy C.M. Lau, et al.. (2005). Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target. Cancer Research. 65(12). 5153–5162. 392 indexed citations

20.

Chua, Chee Wai, Ming‐Tat Ling, Chun Zhou, et al.. (2005). FTY720, a fungus metabolite, inhibits in vivo growth of androgen‐independent prostate cancer. International Journal of Cancer. 117(6). 1039–1048. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact